Vacancies Sort by NameExpiration Date Order AscDesc There are currently no vacancies at the Access Campaign. Click here for more openings at MSF International. Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Read, watch, share Filter by - Any -BlogCampaignEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Feature story Feature story | 29 February 2024 Our Wishlist for 2024 3 min Statement | 04 February 2020 Tropical & neglected diseases WHO 146th EB -13 (EB146/14) – Neglected tropical diseases 2 min Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min Photograph by Aurelie Baumel Press release Press release | 25 September 2024 Antimicrobial resistance UN Political Declaration on antimicrobial resistance essential step, but concrete action from governments now critical 6 min Letter | 23 September 2024 Diabetes Open letter to Eli Lilly on barriers to accessing diabetes medicines Letter | 23 September 2024 Diabetes Open letter to Sanofi on barriers to accessing diabetes medicines Photo credit: Carmen Yahchouchi/MSF 23 September 2024 Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible 4 min Letter | 23 September 2024 Diabetes Open letter to Novo Nordisk on barriers to accessing diabetes medicines Load More
Statement | 04 February 2020 Tropical & neglected diseases WHO 146th EB -13 (EB146/14) – Neglected tropical diseases 2 min
Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min
Photograph by Aurelie Baumel Press release Press release | 25 September 2024 Antimicrobial resistance UN Political Declaration on antimicrobial resistance essential step, but concrete action from governments now critical 6 min
Letter | 23 September 2024 Diabetes Open letter to Eli Lilly on barriers to accessing diabetes medicines
Letter | 23 September 2024 Diabetes Open letter to Sanofi on barriers to accessing diabetes medicines
Photo credit: Carmen Yahchouchi/MSF 23 September 2024 Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible 4 min
Letter | 23 September 2024 Diabetes Open letter to Novo Nordisk on barriers to accessing diabetes medicines